BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3704510)

  • 1. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year].
    Kahn MF; Bourgeois P; Brion N; Elleuch M
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):35-8. PubMed ID: 3704510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine therapy in systemic sclerosis.
    Jayson MI; Lovell C; Black CM; Wilson RS
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H; Tausch G; Eberl R
    Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tiopronin in 69 cases of rheumatoid polyarthritis treated earlier with D-penicillamine].
    Sigaud M; Maugars Y; Maisonneuve H; Prost A
    Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):467-71. PubMed ID: 3134689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?
    Hagdrup H; Serup J; Tvedegaard E
    Acta Derm Venereol; 1983; 63(5):447-9. PubMed ID: 6197850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G
    Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tiopronine and rheumatoid polyarthritis].
    Amor B; Mery C; de Gery A; Zizi M
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):39-43. PubMed ID: 3704511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
    Høyer H; Hvid-Jacobsen K; Weismann K
    Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Madecassol treatment of systemic and localized scleroderma].
    Guseva NG; Starovoĭtova MN; Mach ES
    Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma].
    Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM
    Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994
    [No Abstract]   [Full Text] [Related]  

  • 17. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF; Manzato LC; Samara AM
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Penicillamine in the treatment of patients with systemic scleroderma].
    Gandzha IM
    Vrach Delo; 1987 May; (5):66-7. PubMed ID: 3617690
    [No Abstract]   [Full Text] [Related]  

  • 19. D-penicillamine in the treatment of localized scleroderma.
    Falanga V; Medsger TA
    Arch Dermatol; 1990 May; 126(5):609-12. PubMed ID: 2334179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis.
    Camus JP; Crouzet J; Prier A; Bergevin H
    J Rheumatol Suppl; 1981; 7():175-7. PubMed ID: 6939882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.